Close
CDMO Safety Testing 2026
Novotech

Bora Pharmaceutical makes strategic appointment to strengthen global manufacturing capabilities

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...
- Advertisement -

Bora Pharmaceuticals, a full-service contract development andย manufacturing organization (CDMO), has appointed Don Liscombe as their Vice President andย General Manager to lead its flagship manufacturing facility in North America, located in Mississauga,ย  Ontario, Canada.

Don will be responsible for leading the ambitious growth plans for the Mississauga facility and itsย  current 400 strong workforce. Bringing a wealth of experience in pharmaceutical operations and theย  contract manufacturing industry, Don is recognized for driving profitable growth through customerย  service, employee engagement and a commitment to operational excellence. He has heldย  progressively senior roles in the industry, including General Manager and most recently as leader ofย  Regional Operational excellence at a global CDMO.

Commenting on his appointment, Don Liscombe said โ€œI am privileged to serve in an industry thatย  has a profound impact on peopleโ€™s lives, and I am honoured to join the Bora team whose mission isย  โ€œContributing to Better Health All Over the Worldโ€.

โ€œI am impressed by the companyโ€™s track record of delivering top-tier services to their customers andย  I am truly excited to be joining them at a time of significant growth to reach more patient around theย  worldโ€.

Bobby Sheng, CEO of Bora Pharmaceuticals commented; โ€œwe are delighted to be in a position toย  attract a leader like Don into the organization, he brings invaluable CDMO knowledge andย  experience to the team, and will help drive us towards our impressive growth strategy.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...

Avenda Health Expands Unfold AI Into Midwest Cancer Care

Avenda Health said the University of Michigan Health Weiser...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป